Prospective Study on Febrile Batteries in Pediatric Oncohaematological Patients (SuBiTo)
NCT06419426 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2024-05-17
Summary
The aim of this study is to define prospectively the incidence of multi-resistant germ batteries in paediatric oncoematological patients, to assess associated mortality, antibiotic resistance profile and the type of implemented therapy.
Conditions
Interventions
- OTHER
-
Battery incidence
Incidence of batteries from negative Gram germs; Incidence of batteries from gram positive germs; Incidence of fungemie; Incidence of septic shock; Incidence of batteries from colonising germs; Incidence of resistance to the main classes of antibiotics
Sponsors & Collaborators
-
Associazione Italiana Ematologia Oncologia Pediatrica
lead OTHER
Eligibility
- Min Age
- 1 Month
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-22
- Primary Completion
- 2023-12-31
- Completion
- 2024-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Innovative Reagents for Improving Rapid Diagnosis of Mycobacterial Infections
NCT03808636 ·Status: UNKNOWN
-
Identification and Validation of Clinical Phenotypes in Staphylococcus Aureus Bacteremia and Their Association With Mortality and Development of Complicated Bacteremia
NCT06574399 ·Status: RECRUITING
-
Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness
NCT05172063 ·Status: UNKNOWN
-
Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa
NCT04618198 ·Status: UNKNOWN ·Phase: PHASE3
-
Rapid Detection of Staphylococcus Aureus in Burn Patients
NCT01140269 ·Status: COMPLETED ·Phase: NA
-
Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus)
NCT01589185 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis
NCT02684240 ·Status: COMPLETED ·Phase: PHASE2
-
Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
NCT03716024 ·Status: COMPLETED ·Phase: PHASE2
-
Epidemiological Study on Invasive Bacterial Diseases
NCT06322290 ·Status: RECRUITING
-
Clinical Performance Study of Microbio InfectID-BSI for Detection of Bacteria and Yeast With Patient Blood Samples
NCT06531031 ·Status: NOT_YET_RECRUITING
-
TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
NCT00523926 ·Status: COMPLETED ·Phase: PHASE2
-
Genetic Diversity of Toxoplasma Gondii in Cancer Patients
NCT04834076 ·Status: UNKNOWN
-
Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients
NCT01951430 ·Status: COMPLETED
-
Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
NCT00228982 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia
NCT06594250 ·Status: RECRUITING
-
The Natural History of Community-Associated MRSA Infections and Decolonization Strategies
NCT00513799 ·Status: COMPLETED ·Phase: NA
-
Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant
NCT00518076 ·Status: UNKNOWN
-
PanACEA Sutezolid Dose-finding and Combination Evaluation
NCT03959566 ·Status: COMPLETED ·Phase: PHASE2
-
Burden of Staphylococcus Lugdunensis Infections in Hospitalized Patients
NCT04318262 ·Status: UNKNOWN
-
Diagnostic Evaluation Study of the BactInsight Blood Culture System in West-Africa
NCT05722184 ·Status: COMPLETED
-
Predictors of Infective Endocarditis Among Patients Managed for Staphylococcus Aureus Bacteremia, Particularly Staphylococcus Aureus Bacteriuria, and Time to Blood Culture Positivity
NCT05522764 ·Status: UNKNOWN
-
Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections
NCT01967225 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne
NCT02557568 ·Status: COMPLETED ·Phase: NA
-
Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
NCT03162250 ·Status: COMPLETED ·Phase: PHASE1
-
Prognosis of Disseminated and Cerebral Toxoplasmosis Hospitalized in Intensive Care in the Era of PCR Diagnosis
NCT06305468 ·Status: RECRUITING